Study suggests ways to block hypertension in those with sleep apnea

August 16, 2016
Illustration of obstruction of ventilation. Credit: Habib M’henni / public domain

Obstructive sleep apnea - a disorder that affects nearly one out of four people between the ages of 30 and 70 - is a common cause of high blood pressure. In the Aug. 17, 2016, issue of the journal Science Signaling, researchers based primarily at the University of Chicago describe the signaling cascade that leads to this form of hypertension and suggest ways to disrupt those signals and prevent elevated blood pressures.

"Our results, using a rodent model, establish a mechanism that is the cause of apnea-associated ," said study leader Nanduri Prabhakar, PhD, director of the Institute for Integrative Physiology and Center for Systems Biology of Oxygen Sensing at the University of Chicago. "They also offer a novel way to block the process, preventing this form of hypertension and restoring normal blood pressures."

The connection between and begins in the carotid body, a small cluster of cells located in the carotid arteries, which pass through the right and left sides of the neck. Chemosensory cells in the carotid bodies constantly measure in the blood and use that information to regulate breathing.

When people with sleep apnea periodically slow or stop their breathing during sleep, their blood-oxygen levels plummet. The carotid bodies recognize this deficit and quickly release signals to increase breathing and bring oxygen levels back to normal. These signals, however, can also increase blood pressure, which can lead to strokes during sleep.

"In both central and , the acute elevations in blood pressure associated with apneic episodes may predispose patients to hemorrhagic stroke, while chronic hypertension increases the risk of heart failure," the authors wrote. "Thus, controlling hypertension in sleep apnea patients is a major clinical problem."

So the researchers carefully mapped out the chain of signaling events that began with sleep-disordered breathing and led to the onset of hypertension.

When an episode of apnea causes low , the carotid bodies quickly detect the decrease and begin to generate reactive oxygen species (a natural byproduct of the normal metabolism of oxygen). These inactivate heme oxygenase-2, an enzyme that generates carbon monoxide (CO). This leads to an increase in , which stimulates the carotid bodies to send out chemical signals to take in more oxygen.

Unfortunately, those signals also stimulate the sympathetic nervous system and cause blood vessels to constrict, boosting blood pressure. The standard therapies for hypertension caused by constricted vessels "do not work in this form of hypertension," Prabhakar said.

In the 1960s, when the relationship between the carotid bodies and asthma was being first investigated, researchers tried to treat the disease by surgical removal of the carotid bodies. However, some of those patients developed sleep apnea. Although carotid body resection prevented hypertension, that approach came with serious side effects. Because they lacked the urge to breathe more during exertion, patients were unable to exercise safely, Prabhakar said, adding that "some died in their sleep from extended apneic episodes."

The authors suggest instead that drugs designed to inhibit the enzyme cystathionine-y-lyase - required for the production of hydrogen sulfide, the signal to increase oxygen intake - could be used to disrupt the cascade of signals leading to apnea-related hypertension.

"A major finding of the present study is that blockade of hydrogen sulfide synthesis is sufficient to prevent carotid body activation and hypertension in intermittent hypoxia-exposed rodents," the authors note. Treating rats with a cystathionine-y-lyase inhibitor L-propargylglycine (L-PAG) "restored normal carotid body function, sympathetic nerve activity and , and blocked hypertensive responses to simulated apneas."

"Our results," they conclude, "suggest that inhibiting cystathionine-y-lyase to reduce hydrogen sulfide signaling in the with more potent inhibitors than L-PAG may be a novel approach to treat hypertension in patients with sleep apnea."

Explore further: Hard-to-treat hypertension may jeopardize sleep apnea patients' heart health

More information: Science Signaling, DOI: 10.1126/scisignal.aaf3204

Related Stories

Hard-to-treat hypertension may jeopardize sleep apnea patients' heart health

July 18, 2016
In a study of patients with hypertension, those with resistant hypertension—meaning that their blood pressure remained elevated despite concurrent use of three antihypertensive agents of different classes—had a higher ...

Breathless: How blood-oxygen levels regulate air intake

April 21, 2015
Researchers have unraveled the elusive process by which small, highly vascular clusters of sensory cells in the carotid arteries "taste the blood," as a 1926 essay put it—the initial step in regulating blood-oxygen levels.

Obstructive sleep apnea-induced hypertension linked to gut microbiome

February 9, 2016
Obstructive sleep apnea increases the risk of hypertension, however the link between apneas and high blood pressure is unknown. So what is the connection? Researchers at Baylor College of Medicine say the answer could be ...

Study finds no link between sleep apnea and joint pain

August 1, 2016
Consistent with previous reports, poor sleep quality was linked with joint pain in a recent Arthritis Care & Research study of the general population, but the study found no association between obstructive sleep apnea and ...

Sleep apnea and pre-eclampsia share a common warning sign

June 27, 2013
Many, but not all, people with sleep apnea develop high blood pressure. In a new study, Yale researchers show those who develop hypertension have many similarities with pregnant woman with pre-eclampsia.

Why apnea patients are prone to suffer from glaucoma

July 22, 2016
Scientists at Hokkaido University have successfully measured the eye pressure of sleeping patients with obstructive sleep apnea syndrome for the first time, finding an unexpected correlation with glaucoma.

Recommended for you

Inflammation may precede sleep apnea, could be treatment target

September 1, 2017
Inflammation is traditionally thought of as a symptom of sleep apnea, but it might actually precede the disorder, potentially opening the door for new ways to treat and predict sleep apnea, according to researchers.

More evidence: Untreated sleep apnea shown to raise metabolic and cardiovascular stress

August 31, 2017
Sleep apnea, left untreated for even a few days, can increase blood sugar and fat levels, stress hormones and blood pressure, according to a new study of sleeping subjects. A report of the study's findings, published in the ...

Sleep patterns contribute to racial differences in disease risk

August 18, 2017
Poor sleep patterns could explain, in part, the differences in the risk of cardiometabolic disease between African-Americans and European-Americans, according to a new study published in Proceedings of the National Academy ...

Concerns that sleep apnea could impact healthspan

July 27, 2017
The number of people with obstructive sleep apnea has steadily increased over the past two decades. The disorder, which causes a person to briefly stop breathing when asleep, affects over 100 million people globally and is ...

Anti-nausea drug could help treat sleep apnea

June 6, 2017
An old pharmaceutical product may be a new treatment for obstructive sleep apnea, according to new research presented today by University of Illinois at Chicago and Northwestern University scientists at the SLEEP 2017 annual ...

New disposable, wearable patch found to effectively detect sleep apnea

June 4, 2017
Results of a definitive clinical trial show that a new, disposable diagnostic patch effectively detects obstructive sleep apnea across all severity levels.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.